Abosyn, as a subsidiary of Medinoah Company, Inc., is dedicated to establishing an e-commerce service platform that bridges the gap between supply and demand for global pharmaceutical R&D firms. Drawing from Medinoah's extensive experience and sterling reputation in small molecule drug research and development, Abosyn has developed a range of products, including building blocks, pharmaceutical intermediates, and APIs, which are available in quantities ranging from milligrams to kilograms, and even extend to larger-scale commercial production. Our flagship product series is designed to comprehensively fulfill the diverse needs of worldwide end-users.